SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032278
Filing Date
2024-08-14
Accepted
2024-08-14 16:33:39
Documents
39
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 359414
2 ex31-1.htm EX-31.1 18038
3 ex32-1.htm EX-32.1 6879
  Complete submission text file 0001493152-24-032278.txt   2045829

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20240630.xsd EX-101.SCH 14745
5 XBRL CALCULATION FILE glsi-20240630_cal.xml EX-101.CAL 21807
6 XBRL DEFINITION FILE glsi-20240630_def.xml EX-101.DEF 73518
7 XBRL LABEL FILE glsi-20240630_lab.xml EX-101.LAB 147158
8 XBRL PRESENTATION FILE glsi-20240630_pre.xml EX-101.PRE 127206
41 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 178412
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 241208718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)